Approval · Notice of Compliance 12729 · 2011
DEFINITY: Notice of Compliance 12729
Issued October 17, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12729
- Date
- October 17, 2011
- Company
- Lantheus Mi Canada IncMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Providing Results of Post Market Commitments Regarding the Safe use of Definity, and Resulting Updates to the Product Monograph
- Therapeutic class
- Contrast Enhancing Imaging Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DEFINITY | Not yet assigned | — |
Medicinal ingredients
- PERFLUTREN 150 MCL per ML